Join
Live feed
·
INSIDERFilingvia Quantisnow
Traws Pharma Inc. logo

Chief Executive Officer Dukes Iain D. was granted 36,943 shares, increasing direct ownership by 28% to 171,130 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRAW· Traws Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAW (Traws Pharma Inc.) and more on Quantisnow.